Jeannie Chern, MD, discusses challenges with germline molecular testing for patients with ovarian cancer.
Jeannie Chern, MD
Advertisement
Articles by Jeannie Chern, MD
Jeannie Chern, MD, a gynecologic oncologist at Moffitt Cancer Center, discusses important germline and somatic mutations to be aware of in ovarian cancer.
Advertisement
Latest Updated Articles
Dr. Chern on Important Germline and Somatic Mutations in Ovarian CancerPublished: February 18th 2020 | Updated:
Dr. Chern on Challenges Regarding Germline Testing in Ovarian CancerPublished: March 3rd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5